⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

August 8, 2024Open Access

Table S1 from The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors

Caroline E. Dravillas Samuel S. Coleman Rebecca Hoyd Griffin Caryotakis Louis Denko Carlos H.F. Chan Michelle L. Churchman Nicholas Denko Rebecca D. Dodd Islam Eljilany Sheetal Hardikar Marium Husain Alexandra P. Ikeguchi Ning Jin Qin Ma Martin D. McCarter Afaf E.G. Osman Lary A. Robinson Eric A. Singer Gabriel Tinoco Cornelia M. Ulrich Yousef Zakharia Daniel Spakowicz Ahmad A. Tarhini Aik Choon Tan

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

The list of published gene signatures compared between treatment responders and non-responders and to tumor microbe abundances.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dravillas et al. (2024) studied this question.

synapsesocial.com/papers/68e5d116b6db6435875674dc https://doi.org/10.1158/2767-9764.26519599

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S1 from The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors2024
2Table S3 from The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors2024
3Table S3 from The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors2024
4Table S2 from The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors2024
5Table S2 from The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors2024
6Table S5 from The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors2024
7Table S5 from The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors2024
8Table S4 from The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors2024